1A8 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Accelerate Diagnostics Inc

Watchlist Manager

Watchlist

Price: 6.3 EUR Market Closed

Market Cap: €628.9m

A	Accelerate Diagnostics Inc F:1A8	US
Y	Yara International ASA XBER:IU2	NO
G	General Electric Co DUS:GCP	US
A	Amphenol Corp LSE:0HFB	US
	Anima Holding SpA MIL:ANIM	IT
	Ferrovial SA F:UFG	ES
	Banca Mediolanum SpA F:ME1	IT
T	Transurban Group SWB:TU9	AU
B	Banco Santander SA DUS:BSD2	ES
	Ironman International Ltd XTSX:IMI	CA
N	Novo Nordisk A/S OTC:NONOF	DK
L	Lundin Mining Corp XMUN:GXD	CA
M	Medallion Financial Corp F:MD5	US

Profitability Summary

Accelerate Diagnostics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

23%

Sustainable 3Y Average Gross Margin

28%

Declining Gross Margin

28% > 23%

Negative Operating Margin

-302%

Negative 3Y Average Operating Margin

-422%

Operating Margin is Increasing

-500% > -302%

Negative Net Margin

-428%

Negative 3Y Average Net Margin

-490%

Net Margin is Increasing

-522% > -428%

Negative Free Cash Flow Margin

-211%

Negative 3Y Average Free Cash Flow Margin

-315%

Free Cash Flow Margin is Increasing

-394% > -211%

Exceptional ROE

132%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-378%

ROIC is Increasing

-382% > -340%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.